LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 51.53 | 21.74 | 2363 | 5150 | 0.4588 | 0.8119 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 51.53 | 21.74 | 1882 | 5150 | 0.3654 | 0.7604 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 51.53 | 21.74 | 1908 | 5150 | 0.3704 | 0.7634 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.50 | 21.74 | 1257 | 5425 | 0.2317 | 0.6645 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.50 | 21.74 | 1957 | 5425 | 0.3607 | 0.7596 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.50 | 21.74 | 790 | 5425 | 0.1456 | 0.5702 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.50 | 21.74 | 2551 | 5425 | 0.4702 | 0.8192 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.50 | 21.74 | 2059 | 5425 | 0.3795 | 0.7709 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.50 | 21.74 | 2081 | 5425 | 0.3835 | 0.7732 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 55.48 | 21.74 | 1479 | 5768 | 0.2564 | 0.6890 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 55.48 | 21.74 | 2019 | 5768 | 0.3500 | 0.7555 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 55.48 | 21.74 | 1149 | 5768 | 0.1992 | 0.6368 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 55.48 | 21.74 | 2728 | 5768 | 0.4729 | 0.8224 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 55.48 | 21.74 | 2259 | 5768 | 0.3916 | 0.7802 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 55.48 | 21.74 | 2282 | 5768 | 0.3956 | 0.7824 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 57.45 | 21.74 | 1917 | 6023 | 0.3183 | 0.7368 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 57.45 | 21.74 | 2271 | 6023 | 0.3770 | 0.7735 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 57.45 | 21.74 | 1419 | 6023 | 0.2356 | 0.6736 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 57.45 | 21.74 | 2937 | 6023 | 0.4876 | 0.8306 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 57.45 | 21.74 | 2399 | 6023 | 0.3983 | 0.7855 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 57.45 | 21.74 | 2427 | 6023 | 0.4029 | 0.7880 | MN20160310_N01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 59.42 | 21.74 | 2333 | 6125 | 0.3809 | 0.7763 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 59.42 | 21.74 | 2425 | 6125 | 0.3959 | 0.7848 | MN20160310_N01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 59.42 | 21.74 | 1724 | 6125 | 0.2815 | 0.7115 | MN20160310_N01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 59.42 | 21.74 | 3125 | 6125 | 0.5102 | 0.8413 | MN20160310_N01 | F14 |